Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000217993 | SCV000112757 | likely benign | not specified | 2014-10-02 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000217993 | SCV000270135 | likely benign | not specified | 2015-03-21 | criteria provided, single submitter | clinical testing | p.Phe3228Leu in exon 67 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (49/8265) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs141392048). |
Ambry Genetics | RCV000250763 | SCV000320230 | benign | Cardiovascular phenotype | 2017-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000990576 | SCV000560820 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000217993 | SCV000721717 | benign | not specified | 2017-07-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Advanced Laboratory Medicine, |
RCV000853036 | SCV000995793 | benign | Cardiomyopathy | 2019-04-17 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990576 | SCV001141590 | benign | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490704 | SCV002795558 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-12-02 | criteria provided, single submitter | clinical testing | |
CSER _CC_NCGL, |
RCV000148462 | SCV000190161 | likely benign | Primary dilated cardiomyopathy | 2014-06-01 | no assertion criteria provided | research | |
Natera, |
RCV001826768 | SCV002077648 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-03-27 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004529847 | SCV004750677 | benign | DMD-related disorder | 2024-01-04 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |